RET Y791F Recombinant humaan actief eiwit Kinase

Rearranged during transfection (RET) is a transmembrane receptor protein tyrosine kinase (PTK) activated normally by forming ternary complexes with its cognate ligands and co-receptors. RET alterations by point mutations and gene fusions were found in diverse cancers. RET Y791F is a mutant of RET. RET Y791F Recombinant Human Active Protein Kinase is a recombinant RET Y791F protein that can be used to study RET Y791F-related functions[1].

12352211

RET

Protein Tyrosine Kinase/RTK

Cancer

[RETY791FRecombinantHumanActiveProteinKinase]

[1]Liu X, et al. RET kinase alterations in targeted cancer therapy. Cancer Drug Resist. 2020 May 11;3 (3) :472-481.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-E70780/

Enzyme

No Development Reported